You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Details for Patent: 10,385,341


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,385,341 protect, and when does it expire?

Patent 10,385,341 protects QALSODY and is included in one NDA.

This patent has fifty-nine patent family members in twenty-five countries.

Summary for Patent: 10,385,341
Title:Compositions for modulating SOD-1 expression
Abstract:Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).
Inventor(s):Swayze Eric E.
Assignee:Biogen MA Inc.
Application Number:US15301004
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,385,341: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 10,385,341, providing a detailed analysis of its claims, the patent landscape, and relevant legal and technical contexts.

Overview of the Patent

United States Patent 10,385,341, hereafter referred to as the '341 patent, is a utility patent granted by the U.S. Patent and Trademark Office (USPTO). To analyze this patent, one must first identify its key components, including the title, abstract, background, summary, and most importantly, the claims.

Title and Abstract

The title of the patent provides a brief description of the invention, while the abstract offers a concise summary of the disclosure. These elements are critical for initial assessments and searches.

Background and Summary

The background section typically discusses the prior art and the problems addressed by the invention. The summary section outlines the main aspects of the invention and its advantages over existing solutions.

Claims Analysis

Independent Claims

Independent claims are the broadest claims in a patent and define the scope of the invention. They are not dependent on any other claims and stand alone. For example, Claim 1 of the '341 patent would be an independent claim that sets the foundation for the invention's scope.

Dependent Claims

Dependent claims narrow down the scope of the invention by adding specific limitations to the independent claims. These claims are dependent on the independent claims and cannot stand alone. For instance, Claim 2 might depend on Claim 1 and add additional features or constraints.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is often a critical step in patent litigation, as the interpretation of claims can significantly impact the outcome of a case. The courts use various tools, including the patent specification, prosecution history, and extrinsic evidence, to construe the claims[5].

Patent Landscape

Prior Art

Prior art refers to any publicly available information that existed before the filing date of the patent application. Understanding prior art is essential to determine the novelty and non-obviousness of the invention. The '341 patent would have been examined against prior art to ensure it meets these criteria.

Related Patents

Identifying related patents involves searching for patents that are similar in scope or technology. Tools like the USPTO's Patent Public Search and Global Dossier can be used to find related patents and understand the broader patent landscape[4].

Legal Context

Patent Litigation

Patent litigation often revolves around the interpretation and enforcement of patent claims. The increase in patent infringement lawsuits, particularly those involving software-related patents, highlights the importance of precise claim drafting and thorough prior art searches[1].

America Invents Act (AIA)

The AIA introduced significant changes to the U.S. patent system, including the shift from a first-to-invent to a first-to-file system. This act also impacted patent litigation by limiting the number of defendants in a lawsuit, which can affect how patent holders strategize their legal actions[1].

Technical Context

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications. This dataset can be used to analyze trends in patent scope and claim construction, offering insights into how patents like the '341 patent fit into the broader technical landscape[3].

Practical Implications

Patent Search and Examination

Conducting a thorough patent search is crucial to ensure the novelty and non-obviousness of an invention. The USPTO provides various tools, including the Patent Public Search and Patent and Trademark Resource Centers (PTRCs), to assist in this process[4].

Inter Partes Review (IPR)

IPR is a process by which the Patent Trial and Appeal Board (PTAB) reviews the validity of patent claims. This process can be relevant if the '341 patent is challenged, as seen in cases like Arbutus Biopharma Corporation v. Moderna Therapeutics, Inc.[5].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of the patent.
  • Patent Landscape: Identifying prior art and related patents helps in assessing the novelty and non-obviousness of the invention.
  • Legal Context: Changes in patent law, such as those introduced by the AIA, can significantly impact patent litigation strategies.
  • Technical Context: Datasets and tools provided by the USPTO can offer valuable insights into patent trends and scope.
  • Practical Implications: Thorough patent searches and understanding IPR processes are essential for maintaining and enforcing patent rights.

FAQs

What is the primary purpose of independent claims in a patent?

Independent claims define the broadest scope of the invention and stand alone without depending on other claims.

How does the America Invents Act (AIA) impact patent litigation?

The AIA introduced changes such as limiting the number of defendants in a lawsuit and shifting from a first-to-invent to a first-to-file system, which can affect patent litigation strategies.

What is the role of the Patent Claims Research Dataset in patent analysis?

The dataset provides detailed information on claims from U.S. patents and applications, helping to analyze trends in patent scope and claim construction.

What is Inter Partes Review (IPR), and how does it relate to patent validity?

IPR is a process by which the PTAB reviews the validity of patent claims. It can be used to challenge the validity of patents, as seen in cases like Arbutus Biopharma Corporation v. Moderna Therapeutics, Inc.

Where can one find resources to conduct a thorough patent search?

Resources include the USPTO's Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs)[4].

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation Could Help Improve Patent Quality, GAO-13-465, August 2013.
  2. USPTO: U.S. Patent and Trademark Office, USA.gov.
  3. USPTO Economic Working Paper: Patent Claims and Patent Scope, USPTO Economic Working Paper 2016-04.
  4. USPTO Patent Search: Search for patents, USPTO.
  5. CAFC Opinion: ARBUTUS BIOPHARMA CORPORATION v. MODERNATX, INC., CAFC, April 11, 2023.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,385,341

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Biogen Ma QALSODY tofersen SOLUTION;INTRATHECAL 215887-001 Apr 25, 2023 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,385,341

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3126499 ⤷  Subscribe CR 2024 00038 Denmark ⤷  Subscribe
European Patent Office 3126499 ⤷  Subscribe 301293 Netherlands ⤷  Subscribe
Australia 2015240761 ⤷  Subscribe
Australia 2019268063 ⤷  Subscribe
Australia 2022200002 ⤷  Subscribe
Australia 2024202423 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.